PDAC
Clinical trials for PDAC explained in plain language.
Never miss a new study
Get alerted when new PDAC trials appear
Sign up with your email to follow new studies for PDAC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets Hard-to-Treat cancers with RAS mutations
Disease control Not yet recruitingThis study tests a new drug called GFH276 for people with advanced cancers that have a specific genetic change called RAS mutation. The cancers include pancreatic, lung, and colorectal cancer. The goal is to find a safe dose and see if the drug can shrink tumors. About 450 adults…
Matched conditions: PDAC
Phase: PHASE1, PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated Jun 22, 2026 12:09 UTC
-
Massive cancer registry aims to unlock better GI cancer care
Knowledge-focused Not yet recruitingThis study is a registry that collects medical information and biological samples from up to 100,000 people with gastrointestinal cancers, such as pancreatic or colorectal cancer. No new treatments or drugs are given. The goal is to gather real-world data to help researchers answ…
Matched conditions: PDAC
Sponsor: Canopy Cancer Collective, LLC • Aim: Knowledge-focused
Last updated Jun 23, 2026 12:09 UTC